BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11862731)

  • 1. Nucleic acid test system approval.
    AIDS Alert; 2002 Jan; 17(1):10. PubMed ID: 11862731
    [No Abstract]   [Full Text] [Related]  

  • 2. US FDA approves a new blood screening test for HIV and hepatitis B and C.
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):5. PubMed ID: 19622052
    [No Abstract]   [Full Text] [Related]  

  • 3. Chiron's procleix HIV-1/HCV assay receives FDA approval.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):94. PubMed ID: 11962342
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves new HIV blood test from Roche.
    AIDS Read; 2009 Mar; 19(3):123. PubMed ID: 19338065
    [No Abstract]   [Full Text] [Related]  

  • 6. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
    Ohhashi Y; Pai A; Halait H; Ziermann R
    J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First nucleic acid test approved to detect divergent HIV types.
    AIDS Patient Care STDS; 2009 Apr; 23(4):311. PubMed ID: 19367695
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and Drug Administration approval for 2 new molecular infectious disease assays.
    Press RD
    Mol Diagn; 1999 Sep; 4(3):256. PubMed ID: 10644172
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA issues final guidance on nucleic acid tests.
    AIDS Alert; 2005 Apr; 20(4):46-7. PubMed ID: 15844224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of procleix HIV/HCV RNA diagnostic assay].
    Song AJ; Zhang CT; Li XH; Li J; Wang YC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):36-8. PubMed ID: 16642216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual detection of multiple viral amplicons by dipstick assay: its application in screening of blood donors a welcome tool for the limited resource settings.
    Panhotra BR; Hassan ZU; Joshi CS; Bahrani A
    J Clin Microbiol; 2005 Dec; 43(12):6218; author reply 6218-9. PubMed ID: 16333138
    [No Abstract]   [Full Text] [Related]  

  • 14. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
    Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
    Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
    [No Abstract]   [Full Text] [Related]  

  • 15. HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT).
    O'Riordan J; Williams P; Donnellan J
    Vox Sang; 2005 Nov; 89(4):266. PubMed ID: 16262763
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    Delwart E; Kuhns MC; Busch MP
    J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An FDA-ok'd viral load test? The wait may be nearly over. Food and Drug Administration.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):6-9. PubMed ID: 11363333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection with HIV and HCV in a blood bank population in Dar es Salaam, Tanzania.
    Waddell RD; Magesa PM; Pallangyo KJ; Matee M; Bakari M; von Reyn F; Ziermann R
    J Clin Virol; 2006 Jul; 36(3):237-8. PubMed ID: 16723273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.